ConvaTec Group PLC (LON:CTEC) Receives Average Rating of “Buy” from Brokerages

Shares of ConvaTec Group PLC (LON:CTEC) have been given a consensus rating of “Buy” by the six brokerages that are currently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued ratings on the stock in the last year is GBX 320.33.

A number of equities research analysts have recently weighed in on CTEC shares. JPMorgan Chase & Co. restated an “overweight” rating on shares of ConvaTec Group in a report on Friday, November 14th. UBS Group reiterated a “buy” rating and issued a GBX 375 target price on shares of ConvaTec Group in a research report on Friday, November 7th. Peel Hunt restated an “add” rating and set a GBX 270 price target on shares of ConvaTec Group in a research report on Thursday, November 13th. Finally, Berenberg Bank raised their price objective on ConvaTec Group from GBX 330 to GBX 340 and gave the company a “buy” rating in a research note on Thursday.

ConvaTec Group Stock Performance

LON:CTEC opened at GBX 234.40 on Wednesday. The company has a market capitalization of £4.57 billion, a price-to-earnings ratio of 22.11, a PEG ratio of 0.93 and a beta of 0.64. The business has a 50 day moving average of GBX 236.08 and a 200 day moving average of GBX 237.44. The company has a debt-to-equity ratio of 85.32, a current ratio of 2.26 and a quick ratio of 0.96. ConvaTec Group has a 1-year low of GBX 219.80 and a 1-year high of GBX 311.20.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.